MIAMI – August 1, 2018 – Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that its subsidiary, PharmCo, LLC, has received certification approval from LegitScript to provide verification that it is operating in compliance with applicable laws and regulation set forth to be a safe and credible online health resource.
The LegitScript verification allows the company to begin marketing and advertising PharmCo products and services online. In addition, Progressive Care will be able to move forward with further efforts on its opioid alternative treatment program launched earlier this year. Through this verification, patients and physicians will have the opportunity to learn more about PharmCo’s alternative pain management therapies and how to best integrate these treatments into a medication regimen.
“Progressive Care continues to look for new ways to expand our market share and network of patients, physicians, and providers. This new certification from LegitScript not only showcases the credibility of the PharmCo Pharmacy, but also enables us to continue sharing our message with a larger audience,” said S. Parikh Mars, CEO of Progressive Care Inc. “We are also excited about the new market opportunities this verification presents and believe this additional level of credibility will have a significant impact on company sales moving forward.”
Progressive Care began the verification process with LegitScript in May 2018 and received final approval on July 31, 2018.
Completion of the LegitScript certification process is one of Progressive Care’s many efforts to expand and educate its network. The company recently launched an opioid alternative treatment campaign in an effort to combat the nationwide opioid epidemic. The company also launched DischargeRx, a new proprietary patient engagement program designed to ensure that hospital patients are receiving the best transitional care while preserving vital hospital resources.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Tory Patterson, CMW Media
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development